Literature DB >> 11137393

Cytokines and chemokines in the epidermis.

H Uchi1, H Terao, T Koga, M Furue.   

Abstract

Keratinocytes (KC) produce a vast repertoire of cytokines, including interleukins, growth factors, colony stimulating factors, and chemokines. Under normal conditions, most of them are not synthesized or remain in the cytoplasm, but external stimuli, such as trauma, bacterial infections, chemical substances, or ultraviolet irradiation induce the production and release of these cytokines from KC. KC-derived cytokines regulate the immune and inflammatory responses through their receptors on KC, Langerhans cells, dermal fibroblasts and endothelial cells, and infiltrating T-cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11137393     DOI: 10.1016/s0923-1811(00)00138-9

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  28 in total

1.  Absence of γ-Chain in Keratinocytes Alters Chemokine Secretion, Resulting in Reduced Immune Cell Recruitment.

Authors:  Karolin Nowak; Daniela Linzner; Adrian J Thrasher; Paul F Lambert; Wei-Li Di; Siobhan O Burns
Journal:  J Invest Dermatol       Date:  2017-06-17       Impact factor: 8.551

2.  Assessment of immune activation in mice before and after eradication of mite infestation.

Authors:  Nancy A Johnston; Rita A Trammell; Susan Ball-Kell; Steven Verhulst; Linda A Toth
Journal:  J Am Assoc Lab Anim Sci       Date:  2009-07       Impact factor: 1.232

Review 3.  Early immune events in the induction of allergic contact dermatitis.

Authors:  Daniel H Kaplan; Botond Z Igyártó; Anthony A Gaspari
Journal:  Nat Rev Immunol       Date:  2012-01-13       Impact factor: 53.106

Review 4.  Toll-Like Receptor Function in Acute Wounds.

Authors:  Lin Chen; Luisa A DiPietro
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-10-01       Impact factor: 4.730

5.  A20 and ABIN1 Suppression of a Keratinocyte Inflammatory Program with a Shared Single-Cell Expression Signature in Diverse Human Rashes.

Authors:  Paymann Harirchian; Jerry Lee; Stephanie Hilz; Andrew J Sedgewick; Bethany E Perez White; Michael J Kesling; Thaddeus Mully; Justin Golovato; Matthew Gray; Theodora M Mauro; Elizabeth Purdom; Esther A Kim; Hani Sbitany; Tina Bhutani; Charles J Vaske; Stephen C Benz; Raymond J Cho; Jeffrey B Cheng
Journal:  J Invest Dermatol       Date:  2018-12-10       Impact factor: 8.551

6.  StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial.

Authors:  John M Centanni; Joely A Straseski; April Wicks; Jacquelyn A Hank; Cathy A Rasmussen; Mary A Lokuta; Michael J Schurr; Kevin N Foster; Lee D Faucher; Daniel M Caruso; Allen R Comer; B Lynn Allen-Hoffmann
Journal:  Ann Surg       Date:  2011-04       Impact factor: 12.969

Review 7.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

8.  Transforming growth factor-beta1-mediated Slug and Snail transcription factor up-regulation reduces the density of Langerhans cells in epithelial metaplasia by affecting E-cadherin expression.

Authors:  Michael Herfs; Pascale Hubert; Natalia Kholod; Jean Hubert Caberg; Christine Gilles; Geert Berx; Pierre Savagner; Jacques Boniver; Philippe Delvenne
Journal:  Am J Pathol       Date:  2008-04-01       Impact factor: 4.307

9.  The use of a semiocclusive dressing reduces epidermal inflammatory cytokine expression and mitigates dermal proliferation and inflammation in a rat incisional model.

Authors:  Oliver Kloeters; Clark Schierle; Andrea Tandara; Thomas A Mustoe
Journal:  Wound Repair Regen       Date:  2008 Jul-Aug       Impact factor: 3.617

Review 10.  Changing the Recipe: Pathogen Directed Changes in Tick Saliva Components.

Authors:  Michael Pham; Jacob Underwood; Adela S Oliva Chávez
Journal:  Int J Environ Res Public Health       Date:  2021-02-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.